1. 1) http://www.xofigo.com/hcp/efficacy/overall-survival/ (accessed at June 2017)
2. 2) Drugs@FDA: FDA Approved Drug Products, U.S. Food and Drug Administration, https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=203971 (accessed at June 2017)
3. 3) Xofigo authorization details, European medicines agency, http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002653/human_med_001692.jsp&mid=WC0b01ac058001d124 (accessed at June 2016)
4. 4) Cessna, J. T. and Zimmerman, B. E., Standardization of radium-223 by liquid scintillation counting, Appl. Radiat. Isot., 68, 1523–1528 (2010)
5. 5) Bergeron, D. E., Zimmerman, B. E. and Cessna, J. T., Development of secondary standards for 223Ra, Appl. Radiat. Isot., 68, 1367–1370, discussion, 1370 (2010)